// STATE LEGISLATION TRACKER

Iowa SF 2158: A bill for an act relating to the inspection of compounding pharmacies, and making penalties applicable.

⚖️ MIXED for peptide users 👤 LOW user impact 📜 Status: In committee

State: Iowa
Bill: SF 2158
Session: 2025-2026
Filed: 2026-01-29
Read the bill: OpenStates →
Last reviewed: 2026-10-02

Plain-English Summary

Iowa SF2158 creates a stepwise inspection process for nonsterile compounding pharmacies that are out of compliance with USP 795. It requires notice, follow-up instruction, and mandatory education before allowing a capped fine, and it makes related investigation and remediation records confidential.

Key Points

Applies to nonsterile compounding, not prescribing or telehealth visits
Does not expand or restrict NP, naturopathic, or clinician scope
Could affect pharmacies making nonsterile compounded peptide products
Sets a correction process before penalties for USP 795 issues
Makes certain compounding inspection records unavailable to the public

What to Watch For

Concern Confidential inspection records could make it harder for patients to assess compounding pharmacy quality.

✓

Opportunity A correction-first process may help compliant pharmacies fix problems without immediate heavy penalties.

Note The bill appears focused on nonsterile compounding, so injectable sterile peptide access may be mostly unaffected.

Where the Bill Stands

The bill has been introduced and referred, with a Senate subcommittee assigned but no passage reported.

· Ed. Our analysis pulls public bill metadata from OpenStates and is enriched with research-model context. We don't quote bill text we haven't read directly. If this bill matters to your practice or treatment access, read the official source linked above before taking action. We're an educational research directory, not a legal or medical reference.

Bill page generated 2026-10-02 · enriched via codex gpt-5.5
Source: OpenStates v3 API · View official bill · ← back to all laws